Lincomycins & Polypeptides - Medicinal Chemistry III B. Pharma 6th Semester
Lincomycins & Polypeptides
Contents
• Mechanism of action of Lincomycins
• Study of Individual Lincomycins
• Structures of lincomycin and clindamycin
• Clinical uses of lincomycin and clindamycin
• Polypeptides – Introduction
• Mechanism of action of Polypeptides
Learning Objectives
At the end of this lecture, student will be able to
• Draw the structures of lincomycin and clindamycin
• List clinical applications of lincomycin and clindamycin
• Explain the mechanism of action of Lincomycins and Polypeptides
• Discuss the structural features and uses of individual compounds
Introduction
• Lincomycins are sulfur-containing antibiotics isolated from Streptomyces lincolnensis
• Lincomycin is the most active and medically useful of the compounds obtained from fermentation
• Clindamycin appears to have the greater antibacterial potency and better pharmacokinetic properties
• Lincomycins resemble macrolides in antibacterial spectrum and biochemical mechanisms of action
• They are primarily active against Gram positive bacteria cocci but are also effective against non–spore-forming anaerobic bacteria actinomycetes, mycoplasma and some species of plasmodium
• Food does not interfere with the absorption. Hence it is completely absorbed after oral administration
Mechanism of Action and Resistance
• Lincomycin inhibits protein synthesis in susceptible bacteria by binding to the 50S ribosomal subunit of bacterial ribosomes and preventing peptide bond formation upon transcription.
• It is usually considered bacteriostatic, but may be bactericidal in high concentrations or when used against highly susceptible organisms
• A pattern of bacterial resistance and cross-resistance similar to that observed with the macrolides is seen
Distribution
• Approximately 90% of the antibiotic is plasma bound
• They penetrate most tissues well,including bone
• Hence bone and joint infections caused by suscepitible organisms respond well to treatment with clindamycin
List of Compounds
• Lincomycin
• Clindamycin
Lincomycin
• The structure contains a basic function -the pyrrolidine nitrogen
• Lincomycin is used for the treatment of infections caused by Gram- positive organisms-Staphylococci, hemolytic streptococci, and pneumococci
• It is absorbed moderately well orally and distributed widely in the tissues
• Effective concentrations are achieved in bone for the treatment of staphylococcal osteomyelitis
• But not in the cerebrospinal fluid for the treatment of meningitis
Toxicity:-
• Allergy (rash), occasional gastrointestinal complaints (nausea, vomiting & diarrhea)
• In certain cases – diarrhea & development of pseudomembranous colitis (inflammation of the colon)
Clindamycin Hydrochloride
• Replacement of 7(R)-OH group with 7(S)-Chloro group has increased antibacterial activity & improved absorption
• Clindamycin is recommended for the treatment of a wide variety of upper respiratory, skin, and tissue infections caused by susceptible bacteria
• It is reserved for tissue staphylococcal infections in penicillin-allergic patients & for severe anaerobic infections outside the CNS
• Ordinarily it should not be used to treat respiratory tract infections caused by bacteria sensitive to safer antibiotics or for phophylaxis
Toxicity:-
• Same as lincomycin.
• Clindamycin (or lincomycin) – associated colitis may be particularly dangerous in elderly or debilitated patients and has caused deaths in such individuals.
Polypeptides
• Among the most powerful bactericidal antibiotics
• Possess a polypeptide structure
• Their clinical use has been limited due to undesirable side reactions, particularly renal toxicity.
• Other limitation – lack of systemic activity following oral administration.
Polypeptide antibiotics possess unique characteristics
1. Consists of several structurally similar but chemically distinct entities isolated from a single source.
2. Most of them are cyclic with a few exceptions eg., Gramicidin
3. Contain D-Aminoacids &/of ‘Unnatural’ aminoacids not found in higher plants or animals
4. Many of them contain non-amino acid moieties such as heterocycles, fatty acids, sugars etc.
5. May be acidic, basic, zwitter ionic or neutral depending on the number of free carboxyl & amino or guanidino groups in their structures.
Mechanism of action:-
• These polypeptide antibiotics differ widely in their mechanism of action & antimicrobial properties.
Polypeptide antibiotic combinations | Mechanism of Action | Activity |
1. Bacitracin & Vancomycin (misc. antibiotic) | Interfere with bacterial cell wall synthesis | Effective only against Gram+ve bacteria |
2. Gramicidins & the Polymyxins | Interfere with cell membrane functions in bacteria | Gramicidins-effective only against Gram+ve bacteria Polymyxins-are effective only against Gram-ve species |
Unclassified Antibiotics
Chloramphenicol:-
• Widely used broad-spectrum antibiotic
• Isolated from Streptomyces venejuelae.
Use:-
• In the treatment of serious infections caused by strains of gram +ve and gram –ve bacteria
• As alternative therapy for meningitis.
• In rickettsial infections such as Rocky Mountain Spotted fever.
Synthesis of Chloramphenicol:
Novobiocin:-
• Isolated from Streptomyces spp.
• Bacteriostatic.
• Used in the treatment of Staphyloccocal infections resistant to other antibiotics and sulfas and for patients allergic to these drugs.
• Adverse reactions: - Urticaria (Nettle rash), Allergic rashes
• Hepatotoxicity & Blood dyscrasias.
0 Comments: